$BDMD News

Baird Medical Investment FY EPS $(0.98) Down From $0.57 YoY, Sales $22.537M Down From $37.037M YoY

Baird Medical Advances Clinical Education with Expert-Led Workshops in Indonesia

Baird Medical Expands Global Reach with Regulatory Clearance in Argentina

Baird Medical Investment Receives Argentina's Regulatory Clearance For Its Systems

Baird Medical Accelerates U.S. Expansion in Interventional Thyroidology at NASIT 2026

Baird Medical Accelerates Global Registration of AI-Driven Surgical Software

Baird Medical shares are trading higher after the company announced it has begun the registration process for its surgical software in the U.S., E.U., and China.

Baird Medical shares are trading higher after the company announced it has begun the registration process for its surgical software in the U.S., E.U., and China.

Reported Earlier: Baird Medical Investment Completes Cross-Platform AI Surgical Software, Begins U.S., EU, And China Registration

Baird Medical Accelerates U.S. Expansion at NASOIE 2026

Baird Medical Accelerates U.S. Expansion in Interventional Thyroidology

Baird Medical shares are trading higher after the company announced new clinical progress across the US in interventional thyroidology.

Baird Medical Investment Holdings Expands U.S. Clinical Adoption Of Minimally Invasive Thyroid Treatments

Baird Medical to Showcase Minimally Invasive Thyroid Solutions at Upcoming US Clinical Conferences

Baird Medical Drives U.S. Market Penetration with Commercial Launch at Bakersfield Memorial Hospital

Baird Medical Investment Commercially Deploys Its Technology At Bakersfield Memorial Hospital In California

Baird Medical Accelerates Global Commercial Roadmap with Strategic Clinical Education Initiatives in the U.S. and Japan

Baird Medical Executes Premier Clinical Education Programs In U.S. And Japan

Baird Medical Successfully Concludes Gynecology Microwave Ablation Masterclass

Baird Medical Accelerates Global Commercial Roadmap through Strategic Partnership with Stonewood Key Capital